Insights from the RAD140 Phase 1 Study
The study entitled “A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator RAD140” explores use, tolerability, and pharmacokinetic features of RAD140 Testolone. These are the first clinical trials in humans for RAD140, a selective androgen receptor modulator (SARM) that hopes to deliver muscle gain from testosterone, without the health implications that come…